Veterinary Medicines

Covexin 8

Authorised
  • Clostridium novyi, type B, toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type B, beta toxoid
  • Clostridium septicum, toxoid
  • Tetanus toxoid adsorbed
  • Clostridium haemolyticum, toxoid
Download as PDF

Product identification

Medicine name:
Covexin 8
Active substance:
  • Clostridium novyi, type B, toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type B, beta toxoid
  • Clostridium septicum, toxoid
  • Tetanus toxoid adsorbed
  • Clostridium haemolyticum, toxoid
Target species:
  • Cattle
  • Pig
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium novyi, type B, toxoid
    3.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type C, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Tetanus toxoid adsorbed
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium haemolyticum, toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • A263/79
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."